Genetic Characterization of Brain Metastases in the Era of Targeted Therapy

In the current era of molecularly targeted therapies and precision medicine, choice of cancer treatment has been increasingly tailored according to the molecular or genomic characterization of the cancer the individual has. Previously, the clinical observation of inadequate control of brain metastas...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Catherine H., Brastianos, Priscilla K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622141/
https://www.ncbi.nlm.nih.gov/pubmed/28993799
http://dx.doi.org/10.3389/fonc.2017.00230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622141/
https://www.ncbi.nlm.nih.gov/pubmed/28993799
http://dx.doi.org/10.3389/fonc.2017.00230

Ejemplares similares